Purpose The evidence of a relation between folate intake and one-carbon metabolism (OCM) with pancreatic cancer (PanCa) is inconsistent. In this study, the association between genes and single-nucleotide polymorphisms (SNPs) related to OCM and PanCa was assessed.
Introduction
Impaired DNA methylation is known to cause cancer through induction of chromosomal instability [1] . Folate and related nutrients (homocysteine, cysteine, methionine, cobalamin, and vitamin B6) are thought to influence carcinogenesis through the one-carbon metabolism (OCM) pathway, which is involved in DNA repair, nucleotide synthesis, and methylation [2] . In particular, low folate levels may result in decreased S-adenosyl-methionine levels, the primary donor for methylation reactions. It has been hypothesized that hypomethylation may occur as result of altered folate metabolism [3] . One-carbon metabolites (i.e., folate and related nutrients) have been associated with several types of cancer [4] [5] [6] [7] [8] , and inverse associations with pancreatic cancer (PanCa) have been observed for dietary folate, although study results have been inconsistent [9] [10] [11] [12] [13] [14] [15] [16] . In addition, previous studies in association with PanCa for OCM-related SNPs observed a positive association with PanCa for the MTHFR 677TT genotype [17] and for two SNPs on the MTRR gene (rs162049 and rs10380) [18] . Genome-wide association studies (GWAS) of PanCa have not identified associations with genes involved with OCM [19] [20] [21] [22] [23] [24] .
In the present study, we used a two-stage approach to evaluate whether 31 genes thought to play a role in the OCM pathway (http://wikipathways.org/index.php/Pathway: WP241) were associated with PanCa. Additionally, genes (ALPL, CPS1, CUBN, FUT2, PRICKLE2, and TCN1) that included SNPs previously observed to predict one-carbon metabolite levels in GWAS [25] [26] [27] were also included. The first stage included nested case-control studies from twelve cohorts that participated in the National Cancer Institute (NCI) Pancreatic Cancer Cohort Consortium genome-wide association study (PanScan1) [19] . The second stage, used for replication, included eight case-control studies with GWAS data that participated in the Pancreatic Cancer Case-Control Consortium (PanC4) and were part of PanScan 2 [22] .
Methods
The methods for PanScan1 and PanScan2 are described elsewhere [19, 22] . The study population included PanCa cases and control participants from the previously conducted GWAS in the PanScan1 and PanC4 [19, 22] . The first stage of our analyses included 1,408 incident cases and 1,463 controls from the twelve cohort studies that participated in PanScan1 [19] . The second stage included 2,323 cases and 2,340 controls from eight case-control studies that participated in PanC4 and were part of PanScan1 and PanScan2 [19, 22] . All included studies had available dietary and lifestyle data. Cases were defined as participants diagnosed with primary adenocarcinoma of the exocrine pancreas, and controls were matched to cases according to birth year, sex, and selfreported race/ethnicity and were free of PanCa at the time of recruitment [19, 22] . Genotyping was performed by the NCI Core Genotyping Facility using the Illumina HumanHap550 and HumanHap550-Duo SNP arrays (PanScan1) and Illumina Human 610-Quad arrays (PanScan2) [19, 22] . Each individual study obtained informed consent from study participants and approval from local institutional review board. The Special Studies Institutional Review Board of the NCI approved the pooled PanScan study [19, 22] .
Details of the collection of data across the cohorts are described elsewhere [19] . A total of 37 genes and 834 SNPs were included in the study. From all studies, data on the participant's age and gender were obtained. In addition, five effective principal components or eigenvectors determined from the GWAS data were included as quantitative covariates to correct for population structure.
Data on one-carbon metabolite biomarkers (homocysteine, cysteine, methionine, folate, cobalamin, and vitamin B6) measured in plasma were available for 327 controls of the case-control study nested within the EPIC cohort. Biomarker levels were analyzed by MS-based methods in the laboratory of BEVITAL AS (http://www.bevital.no) in Bergen, Norway [28] .
In the first stage, the association for each SNP with PanCa was examined within the cohorts of PanScan using unconditional logistic regression, adjusted for age and sex. To correct for population stratification, analyses were also adjusted for cohort and five principal components of population stratification. Allelic additive models were used where the risk allele was the least frequent allele. p values were adjusted for multiple testing using the permutationbased closed step-down minP procedure [29] . Genes were evaluated separately using the adaptive rank truncated product (ARTP) method [30] with 20 truncation points, using 10,000 permutations. This captures potential multiple association signals within a gene, accounting for gene size and LD structure. Gene ARTP p values were adjusted for multiple comparisons using a false discovery rate [31] .
The ten SNPs and five genes that showed lowest p values for the association with PanCa in the cohort data were followed up in eight case-control studies from PanC4, using similar analyses. Because fewer comparisons were performed in this second stage, a Bonferroni correction was applied to both SNP and gene p values to adjust for multiple comparisons. Finally, a combined analysis of both stages was performed. Because combined results were mainly driven by cohort results, these were adjusted for multiple comparisons using similar techniques as applied to the first stage.
Adaptive rank truncated product p values also were computed for the total OCM pathway in all stages using the top 5 genes as truncation points. An adjusted p value below 0.05 was considered statistically significant.
Modification of the top ten SNPs by dietary intake of folate (in tertiles) was assessed in the cohorts by testing the statistical significance of the multiplicative interaction terms using likelihood ratio tests. Differences in leastsquares means for plasma metabolite levels (homocysteine, cysteine, methionine, folate, cobalamin, and vitamin B6) were compared per genotype for each SNP by a pairwise t test in controls only.
Results
In the first stage of our analyses (cohort studies), rs10887710 (MAT1A) showed the lowest p value of all tested SNPs (allelic OR 1.24, 95 % CI 1.08-1.41, p 0.002) (Table 1 ). However, after correcting for multiple comparisons, none of the SNPs were statistically significant. None of the top ten SNPs for the first stage showed a relation with PanCa in the second stage (case-control studies), with all p values greater than 0.2. When all studies were combined (cohort and case-control), statistically significant associations were found for rs10887710 (MAT1A), rs1552462 (SYT9), and rs7074891 (CUBN). However, after correcting for multiple comparisons, the associations were not statistically significant.
Two genes (MAT1A, p 0.021 and TYMS, p 0.033) showed statistically significant ARTP p values in the first stage ( Table 2 ). In the replication stage, none of the genes showed an association with PanCa. When both stages were combined, MTRR (p for cohort stage: 0.19) showed a significant p value (p 0.05). After adjustment for multiple comparisons, no significant associations were found in all stages. Additionally, the pathway analysis showed ARTP-adjusted p values above 0.50 in all stages.
There were no significant interactions of the top onecarbon pathway SNPs or genes by dietary folate. Within the subset of EPIC participants with the one-carbon biomarkers, several associations were observed between one-carbon biomarkers and the ten SNPs with the lowest p values in the cohort stage. For three SNPs in TYMS (rs3819101, rs11873007, and rs3786355) that were in high linkage disequilibrium, the TT genotype correlated with higher 
Discussion
This is the largest genetic study to date examining the relation between germline variations in OCM-related genes and PanCa risk. In the first stage of this study (cohort studies), evidence for an association between genes (MAT1A and TYMS) and SNPs (most notably rs10887710 [MAT1A]) involved in OCM with PanCa was observed. However, after correcting for multiple comparisons, these associations were not statistically significant, nor did the suggestive evidence replicate in the second stage (casecontrol studies) of this study. No interaction between dietary folate and any of the ten SNPs with lowest p values in the first stage was observed.
For several of the top ten SNPs, a correlation with onecarbon biomarkers was observed. This indicates that the SNPs possibly directly influence biomarker levels, which could strengthen evidence for a relation between these SNPs and PanCa. However, none of the SNPs replicated in a second stage and correlations with biomarkers could only be calculated from a subset of all included participants. Additionally, no clear association between onecarbon metabolites and risk of PanCa has been observed within EPIC using the same data on metabolites and PanCa [32] .
The reason for observing no replication of the suggestive evidence observed in the first stage of the study may have been due to differences in study designs, as cohort studies may be less prone to survival bias. However, considering the large number of SNPs tested, it is most likely that the significant SNPs observed in the cohort studies, which did not replicate in case-control studies, were false-positives in the first stage of the analysis.
In conclusion, we observed suggestive associations between SNPs and genes involved in one-carbon metabolism and risk of PanCa in the first stage of this study (cohort studies), but none of the results replicated in the second stage (case-control studies). Our results do not strongly support the hypothesis that genes related to OCM play a role in pancreatic carcinogenesis. 
